{"id":1463,"date":"2020-10-09T09:22:29","date_gmt":"2020-10-09T16:22:29","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=1463"},"modified":"2020-10-12T09:25:57","modified_gmt":"2020-10-12T16:25:57","slug":"1463","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/10\/09\/1463\/","title":{"rendered":"Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19"},"content":{"rendered":"<ul>\n<li>The RECOVERY trial found that patients hospitalized with COVID-19 who received hydroxychloroquine did not have a lower incidence of death by 28 days after enrollment compared to those who received usual care. The randomized open-label platform trial found that patients in the hydroxychloroquine group were less likely to be discharged from the hospital alive within 28 days than those in the usual-care group (60% vs 63%). Among patients who were not on a ventilator at baseline, those in the hydroxychloroquine group had a higher frequency of invasive mechanical ventilation or death (31% vs 27%). There was a small numerical excess of cardiac deaths (0.4%) but no difference in the incidence of new major cardiac arrhythmia among the patients who received hydroxychloroquine.<\/li>\n<\/ul>\n<p>Horby et al. (Oct 8, 2020). Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine. <a href=\"https:\/\/doi.org\/10.1056\/NEJMoa2022926\">https:\/\/doi.org\/10.1056\/NEJMoa2022926<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The RECOVERY trial found that patients hospitalized with COVID-19 who received hydroxychloroquine did not have a lower incidence of death by 28 days after enrollment compared to those who received usual care. The randomized open-label platform trial found that patients in the hydroxychloroquine group were less likely to be discharged from the hospital alive within&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/10\/09\/1463\/\">Read more<\/a><\/div>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[28],"topic":[19],"class_list":["post-1463","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-treatment","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=1463"}],"version-history":[{"count":2,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1463\/revisions"}],"predecessor-version":[{"id":1465,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/1463\/revisions\/1465"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=1463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=1463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=1463"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=1463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}